AdvanSix (NYSE: ASIX), an integrated chemistry company serving diverse end markets, announced today the appointment of ...

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, according to a Phase III trial published in The Lancet. The study found that one ...

Good day, and thank you for standing by. Welcome to the Structure Therapeutics top line results from the aleniglipron Phase II Access Program. [Operator Instructions] Please be advised that today's ...

On November 30, 2025, in Beijing, China, @Shìtánghuǒshāo shared a video of a parrot opening a small square sachet using its beak. In the video, the bird is inside its cage as its owner places the ...

A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial ...

Sometimes it’s hard to go with the flow. While oral medications are generally considered safer and more convenient than injections or inhalations, sometimes a simple swallow is easier said than done.

Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an effective alternative to injections of PCSK9 inhibitors to lower low-density ...

NEW ORLEANS, LA—Use of enlicitide 20 mg, an oral PCSK9 inhibitor, significantly cut levels of LDL cholesterol and other atherogenic lipids in a large cohort of high-risk patients, results from the ...

Enlicitide, an oral PCSK9 inhibitor, reduced LDL-C by nearly 60% in adults with or at risk for ASCVD. The medication offers a daily oral alternative to injectable PCSK9 inhibitors, potentially ...

Growth of enrollment in zero-premium Medicare Advantage (MA) among US counties with high cancer burden. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium. This abstract does ...